Fibroblast Growth Factors
"Fibroblast Growth Factors" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A family of small polypeptide growth factors that share several common features including a strong affinity for HEPARIN, and a central barrel-shaped core region of 140 amino acids that is highly homologous between family members. Although originally studied as proteins that stimulate the growth of fibroblasts this distinction is no longer a requirement for membership in the fibroblast growth factor family.
| Descriptor ID |
D005346
|
| MeSH Number(s) |
D12.644.276.624 D12.776.467.624 D23.529.624
|
| Concept/Terms |
Fibroblast Growth Factors- Fibroblast Growth Factors
- Growth Factors, Fibroblast
- Fibroblast Growth Factor
- Growth Factor, Fibroblast
- Fibroblast Growth Regulatory Factor
- DNA Synthesis Factor
|
Below are MeSH descriptors whose meaning is more general than "Fibroblast Growth Factors".
Below are MeSH descriptors whose meaning is more specific than "Fibroblast Growth Factors".
This graph shows the total number of publications written about "Fibroblast Growth Factors" by people in this website by year, and whether "Fibroblast Growth Factors" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2000 | 0 | 1 | 1 |
| 2003 | 2 | 0 | 2 |
| 2004 | 0 | 2 | 2 |
| 2014 | 0 | 1 | 1 |
| 2015 | 0 | 1 | 1 |
| 2018 | 0 | 1 | 1 |
| 2021 | 3 | 0 | 3 |
| 2023 | 0 | 2 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Fibroblast Growth Factors" by people in Profiles.
-
Postprandial triglycerides and fibroblast growth factor 19 as potential screening tools for paediatric non-alcoholic fatty liver disease. Pediatr Obes. 2023 04; 18(4):e13007.
-
Combining ASBT inhibitor and FGF15 treatments enhances therapeutic efficacy against cholangiopathy in female but not male Cyp2c70 KO mice. J Lipid Res. 2023 03; 64(3):100340.
-
Liver-Specific Nonviral Gene Delivery of Fibroblast Growth Factor 21 Protein Expression in Mice Regulates Body Mass and White/Brown Fat Respiration. J Pharmacol Exp Ther. 2021 08; 378(2):157-165.
-
Negative Regulation of FGFR (Fibroblast Growth Factor Receptor) Signaling. Cells. 2021 05 28; 10(6).
-
Combined ASBT Inhibitor and FGF15 Treatment Improves Therapeutic Efficacy in Experimental Nonalcoholic Steatohepatitis. Cell Mol Gastroenterol Hepatol. 2021; 12(3):1001-1019.
-
An FGF15/19-TFEB regulatory loop controls hepatic cholesterol and bile acid homeostasis. Nat Commun. 2020 07 17; 11(1):3612.
-
Protein Tyrosine Phosphatase Receptor Type G (PTPRG) Controls Fibroblast Growth Factor Receptor (FGFR) 1 Activity and Influences Sensitivity to FGFR Kinase Inhibitors. Mol Cell Proteomics. 2018 05; 17(5):850-870.
-
Alcoholic fatty liver is enhanced in CYP2A5 knockout mice: The role of the PPARa-FGF21 axis. Toxicology. 2017 03 15; 379:12-21.
-
Endothelial MMP14 is required for endothelial-dependent growth support of human airway basal cells. J Cell Sci. 2015 Aug 15; 128(16):2983-8.
-
An in vitro cord formation assay identifies unique vascular phenotypes associated with angiogenic growth factors. PLoS One. 2014; 9(9):e106901.